Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
04 Sep 2024
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-acquires-40-million-shares-in-egenesis-inc/articleshow/113059231.cms
12 Aug 2024
// ECONOMICTIMES
https://health.economictimes.indiatimes.com/news/pharma/financial-performance/natco-pharma-q1-profit-up-59-pc-at-rs-668-cr/112471603?utm_source=top_news&utm_medium=sectionListing
02 May 2024
// HEALTH CANADA
https://www.pharmacompass.com/pdf/news/natco-pharma-on-health-canada-inspection-list-42576.pdf
22 Apr 2024
// BUSINESS STANDARD
https://www.business-standard.com/companies/news/usfda-pulls-up-natco-pharma-for-several-violations-at-telangana-plant-124042100125_1.html
17 Apr 2024
// ENDPTS
https://endpts.com/fda-hits-natco-with-warning-letter-over-india-facility-suspends-product-shipments-to-us/#:~:text=Manufacturer%20Natco%20Pharma%20was%20hit,FDA%20Form%20483%20last%20fall.
17 Apr 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19687
Submission : 2006-08-11
Status : Active
Type : II
Certificate Number : R1-CEP 2014-022 - Rev 00
Issue Date : 2020-01-27
Type : Chemical
Substance Number : 2406
Status : Valid
Registration Number : 223MF10014
Registrant's Address : Natco House, Road No. 2, Banjara Hills,Hyderabad 500034, Telangana, India
Initial Date of Registration : 2011-01-26
Latest Date of Registration :
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-6527
Start Marketing Date : 2016-01-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Classia Co., Ltd.
Registration Date : 2023-05-26
Registration Number : 20230526-209-J-1500
Manufacturer Name : Natco Pharma Limited
Manufacturer Address : Chemical Division Mekaguda Village, Nandigama Mandal Rangareddy District Telangana, 509223, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-04
Pay. Date : 2018-08-10
DMF Number : 32409
Submission : 2018-07-24
Status : Active
Type : II
Certificate Number : CEP 2017-244 - Rev 02
Issue Date : 2024-02-07
Type : Chemical
Substance Number : 2866
Status : Valid
Registration Number : 229MF10197
Registrant's Address : Natco House, Road No. 2, Banjara Hills,Hyderabad 500034, Telangana, India
Initial Date of Registration : 2017-11-09
Latest Date of Registration :
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-8070
Start Marketing Date : 2020-01-04
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2018-11-23
Registration Number : Number 434-7-ND
Manufacturer Name : Natco Pharma Limited
Manufacturer Address : Mekaguda Village, Nandigama Mandal, Rangareddy District, Telangana 509 223, India
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-28
Pay. Date : 2013-09-19
DMF Number : 20410
Submission : 2007-04-05
Status : Active
Type : II
Certificate Number : CEP 2015-273 - Rev 01
Issue Date : 2023-10-02
Type : Chemical
Substance Number : 2736
Status : Valid
Registration Number : 225MF10060
Registrant's Address : Natco House, Road No. 2, Banjara Hills,Hyderabad 500034, Telangana, India
Initial Date of Registration : 2013-03-14
Latest Date of Registration :
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-4826
Start Marketing Date : 2016-01-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Hyundai Bioland Co., Ltd.
Registration Date : 2022-08-04
Registration Number : 22-5-ND(B)
Manufacturer Name : Natco Pharma Limited
Manufacturer Address : Chemical Division, Mekaguda Village, Nandigama Mandal, Rangareddy District, Telagana State, India, Pin:509 223
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-02-23
Pay. Date : 2018-02-12
DMF Number : 18388
Submission : 2005-06-03
Status : Active
Type : II
Certificate Number : R1-CEP 2007-150 - Rev 03
Issue Date : 2017-02-14
Type : Chemical
Substance Number : 2334
Status : Valid
Registration Number : 226MF10005
Registrant's Address : Natco House, Road No. 2, Banjara Hills,Hyderabad 500034, Telangana, India
Initial Date of Registration : 2014-01-08
Latest Date of Registration :
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-7701
Start Marketing Date : 2016-01-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17185
Submission : 2004-02-04
Status : Active
Type : II
Certificate Number : R1-CEP 2009-390 - Rev 01
Issue Date : 2017-02-14
Type : Chemical
Substance Number : 2288
Status : Valid
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-3616
Start Marketing Date : 2016-01-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19215
Submission : 2006-03-03
Status : Active
Type : II
Registration Number : 219MF10373
Registrant's Address : Natco House, Road No. 2, Banjara Hills, Hyderabad 500034, Telangana, India
Initial Date of Registration : 2007-12-19
Latest Date of Registration :
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-7308
Start Marketing Date : 2016-01-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18180
Submission : 2005-02-25
Status : Active
Type : II
Certificate Number : CEP 2003-221 - Rev 05
Issue Date : 2023-10-03
Type : Chemical
Substance Number : 2016
Status : Valid
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-2706
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-06-02
Pay. Date : 2021-05-27
DMF Number : 20781
Submission : 2007-08-21
Status : Active
Type : II
Certificate Number : R1-CEP 2012-268 - Rev 00
Issue Date : 2020-05-15
Type : Chemical
Substance Number : 2585
Status : Valid
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-7119
Start Marketing Date : 2016-01-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-05-27
Pay. Date : 2015-05-08
DMF Number : 18394
Submission : 2005-06-03
Status : Active
Type : II
Certificate Number : R1-CEP 2009-013 - Rev 03
Issue Date : 2023-04-20
Type : Chemical
Substance Number : 1765
Status : Valid
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-3912
Start Marketing Date : 2016-01-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-31
Pay. Date : 2012-12-31
DMF Number : 19523
Submission : 2006-06-15
Status : Active
Type : II
Registration Number : 225MF10053
Registrant's Address : Natco House, Road No. 2, Banjara Hills,Hyderabad 500034, Telangana, India
Initial Date of Registration : 2013-03-12
Latest Date of Registration :
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm :
NDC Package Code : 63850-7104
Start Marketing Date : 2016-01-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Details:
The net proceeds will be used for the development of chimeric antigen receptor T cell therapy program, at an advanced stage for Cellogen Therapeutics, where the T cells of the patients are genetically engineered to identify and kill the cancer cells.
Lead Product(s): CAR-T Cell Therapy
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Cell and Gene therapy
Recipient: Cellogen Therapeutics
Deal Size: $2.0 million Upfront Cash: Undisclosed
Deal Type: Financing January 18, 2024
Lead Product(s) : CAR-T Cell Therapy
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : Cellogen Therapeutics
Deal Size : $2.0 million
Deal Type : Financing
NATCO Invests US$ 2 Million in Cellogen Therapeutics
Details : The net proceeds will be used for the development of chimeric antigen receptor T cell therapy program, at an advanced stage for Cellogen Therapeutics, where the T cells of the patients are genetically engineered to identify and kill the cancer cells.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 18, 2024
Details:
Lenalidomide inhibits proliferation and induces apoptosis of certain hematopoietic tumor cells including MM, mantle cell lymphoma, and del (5q) myelodysplastic syndromes, follicular lymphoma and marginal zone lymphoma.
Lead Product(s): Lenalidomide,Dexamethasone
Therapeutic Area: Oncology Brand Name: Lenalidomide-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Teva Pharmaceutical Industries
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 09, 2023
Lead Product(s) : Lenalidomide,Dexamethasone
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Teva Pharmaceutical Industries
Deal Size : Not Applicable
Deal Type : Not Applicable
Teva and Natco Announce Launch of Additional Strengths for The Generic Version of Revlimid® (Lena...
Details : Lenalidomide inhibits proliferation and induces apoptosis of certain hematopoietic tumor cells including MM, mantle cell lymphoma, and del (5q) myelodysplastic syndromes, follicular lymphoma and marginal zone lymphoma.
Brand Name : Lenalidomide-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 09, 2023
Details:
Yondelis-Generic (trabectedin) is a DNA inhibitor, small molecule drug candidate. It is being developed for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Lead Product(s): Trabectedin
Therapeutic Area: Oncology Brand Name: Yondelis-Generic
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 18, 2022
Lead Product(s) : Trabectedin
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Natco Pharma Gets Tentative Approval for Yondelis Generic
Details : Yondelis-Generic (trabectedin) is a DNA inhibitor, small molecule drug candidate. It is being developed for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
Brand Name : Yondelis-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 18, 2022
Details:
Cabazitaxel Intravenous Powder (generic for Jevtana Kit®), is a Microtubule inhibitor, available in the 60mg/1.5mL (40mg/mL) strength used fo the treatment of Prostate cancer.
Lead Product(s): Cabazitaxel
Therapeutic Area: Oncology Brand Name: Cabazitaxel-Generic
Study Phase: ApprovedProduct Type: Small molecule
Recipient: Breckenridge Pharmaceutical
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 01, 2022
Lead Product(s) : Cabazitaxel
Therapeutic Area : Oncology
Highest Development Status : Approved
Recipient : Breckenridge Pharmaceutical
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Cabazitaxel Intravenous Powder (generic for Jevtana Kit®), is a Microtubule inhibitor, available in the 60mg/1.5mL (40mg/mL) strength used fo the treatment of Prostate cancer.
Brand Name : Cabazitaxel-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
August 01, 2022
Details:
Cabazitaxel intravenous powder of strength 60mg/1.5ml (40mg/ml), is an antineoplastic agent and a microtubule inhibitor used in the treatment of prostate cancer.
Lead Product(s): Cabazitaxel
Therapeutic Area: Oncology Brand Name: Cabazitaxel-Generic
Study Phase: ApprovedProduct Type: Small molecule
Recipient: Breckenridge Pharmaceutical
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 25, 2022
Lead Product(s) : Cabazitaxel
Therapeutic Area : Oncology
Highest Development Status : Approved
Recipient : Breckenridge Pharmaceutical
Deal Size : Not Applicable
Deal Type : Not Applicable
Natco Pharma's Partner Breckenridge Gets FDA Nod for Prostate Cancer Drug
Details : Cabazitaxel intravenous powder of strength 60mg/1.5ml (40mg/ml), is an antineoplastic agent and a microtubule inhibitor used in the treatment of prostate cancer.
Brand Name : Cabazitaxel-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
July 25, 2022
Details:
This agreement allows Natco to expand access to COVID-19 medicines in 105 countries in generic name. Under the licence, Natco can set its own price for the generic products it produces, paying a royalty on sales to MSD.
Lead Product(s): Molnupiravir
Therapeutic Area: Infections and Infectious Diseases Brand Name: Molnunat
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: The Medicines Patent Pool
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 20, 2022
Lead Product(s) : Molnupiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : The Medicines Patent Pool
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Natco Pharma Signs Pact With MPP to Sell Molnupiravir Capsules
Details : This agreement allows Natco to expand access to COVID-19 medicines in 105 countries in generic name. Under the licence, Natco can set its own price for the generic products it produces, paying a royalty on sales to MSD.
Brand Name : Molnunat
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 20, 2022
Details:
Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection in adults who have high risk of progression of the disease including hospitalisation or death.
Lead Product(s): Molnupiravir
Therapeutic Area: Infections and Infectious Diseases Brand Name: Molnunat
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 28, 2021
Lead Product(s) : Molnupiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Natco Pharma Plans to Launch Molnupiravir Capsules This Week for Treatment of COVID-19
Details : Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection in adults who have high risk of progression of the disease including hospitalisation or death.
Brand Name : Molnunat
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 28, 2021
Details:
Natco Pharma launched novel fixed-dose combination of Trifluridine+Tipiracil under the brand name Tipanat, is a novel antineoplastic nucleoside analog indicated for the treatment of advanced colorectal and gastric cancer.
Lead Product(s): Trifluridine,Tipiracil Hydrochloride
Therapeutic Area: Oncology Brand Name: Tipanat
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 18, 2021
Lead Product(s) : Trifluridine,Tipiracil Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Natco Pharma Launches Tipanat Tabs in India to Treat Advanced Colorectal and Gastric Cancer
Details : Natco Pharma launched novel fixed-dose combination of Trifluridine+Tipiracil under the brand name Tipanat, is a novel antineoplastic nucleoside analog indicated for the treatment of advanced colorectal and gastric cancer.
Brand Name : Tipanat
Molecule Type : Small molecule
Upfront Cash : Not Applicable
November 18, 2021
Details:
Molnupiravir is an investigational medicine developed by US based pharma firm Merc used to treat SARS-CoV-2 infection. In India, Merck Pharma Company had signed licensing agreements with various Indian pharma firms like Cipla, Dr Reddy’s, Emcure, Hetero labs and Sun Pharma.
Lead Product(s): Molnupiravir
Therapeutic Area: Infections and Infectious Diseases Brand Name: MK-4482
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: Hetero Biopharma
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 30, 2021
Lead Product(s) : Molnupiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Hetero Biopharma
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Molnupiravir is an investigational medicine developed by US based pharma firm Merc used to treat SARS-CoV-2 infection. In India, Merck Pharma Company had signed licensing agreements with various Indian pharma firms like Cipla, Dr Reddy’s, Emcure, Heter...
Brand Name : MK-4482
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 30, 2021
Details:
Everolimus is the generic name for the trade name drug Afinitor. Breckenridge has launched 10mg strength of Everolimus Tablets used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours.
Lead Product(s): Everolimus
Therapeutic Area: Oncology Brand Name: Undisclosed
Study Phase: ApprovedProduct Type: Small molecule
Recipient: Breckenridge Pharmaceutical
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 01, 2021
Lead Product(s) : Everolimus
Therapeutic Area : Oncology
Highest Development Status : Approved
Recipient : Breckenridge Pharmaceutical
Deal Size : Not Applicable
Deal Type : Not Applicable
Everolimus 10mg (Afinitor) Launched
Details : Everolimus is the generic name for the trade name drug Afinitor. Breckenridge has launched 10mg strength of Everolimus Tablets used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumo...
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
October 01, 2021
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 0.25MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 0.5MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 1MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 2MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 1MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 1MG
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 250MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 500MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Injection
Brand Name :
Dosage Strength : 100MG
Packaging : Injection
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Dosage Form : Tablet
Brand Name :
Dosage Strength : 1MG
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Inspections and registrations
District Decision : Voluntary Action Indicated
Inspection End Date : 2009-02-12
City : Mahabub Nagar
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2009-02-12
District Decision : No Action Indicated
Inspection End Date : 2011-11-18
City : Mahabub Nagar
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2011-11-18
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-05-23
City : Mahabub Nagar
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-05-23
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-01-24
City : Mahaboob Nagar
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2017-01-24
ABOUT THIS PAGE
Natco Pharma Limited is a supplier offers 97 products (APIs, Excipients or Intermediates).
Find a price of Anastrozole bulk with DMF, CEP, JDMF offered by Natco Pharma Limited
Find a price of Gefitinib bulk with DMF, CEP, JDMF offered by Natco Pharma Limited
Find a price of Imatinib Mesylate bulk with DMF, CEP, JDMF offered by Natco Pharma Limited
Find a price of Letrozole bulk with DMF, CEP, JDMF offered by Natco Pharma Limited
Find a price of Citalopram Hydrobromide bulk with DMF, CEP offered by Natco Pharma Limited
Find a price of Granisetron Hydrochloride bulk with DMF, JDMF offered by Natco Pharma Limited
Find a price of Ondansetron Hydrochloride bulk with DMF, CEP offered by Natco Pharma Limited
Find a price of Rizatriptan Benzoate bulk with DMF, CEP offered by Natco Pharma Limited
Find a price of Salmeterol Xinafoate bulk with DMF, CEP offered by Natco Pharma Limited
Find a price of Zoledronic Acid bulk with DMF, JDMF offered by Natco Pharma Limited
Find a price of Omeprazole bulk with DMF, CEP offered by Natco Pharma Limited
Find a price of Sumatriptan bulk with DMF, CEP offered by Natco Pharma Limited
Find a price of Apixaban bulk with DMF offered by Natco Pharma Limited
Find a price of Bendamustine Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Benzhexol hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Bortezomib bulk with DMF offered by Natco Pharma Limited
Find a price of Carmustine bulk with DMF offered by Natco Pharma Limited
Find a price of Chloroquine Phosphate bulk with DMF offered by Natco Pharma Limited
Find a price of Erlotinib Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Everolimus bulk with DMF offered by Natco Pharma Limited
Find a price of Ibandronate Sodium bulk with DMF offered by Natco Pharma Limited
Find a price of Lansoprazole bulk with DMF offered by Natco Pharma Limited
Find a price of Lanthanum Carbonate bulk with DMF offered by Natco Pharma Limited
Find a price of Nilotinib bulk with DMF offered by Natco Pharma Limited
Find a price of Pantoprazole Sodium bulk with CEP offered by Natco Pharma Limited
Find a price of Pomalidomide bulk with DMF offered by Natco Pharma Limited
Find a price of Sertraline Hydrochloride bulk with CEP offered by Natco Pharma Limited
Find a price of Sugammadex Sodium bulk with DMF offered by Natco Pharma Limited
Find a price of Teriflunomide bulk with DMF offered by Natco Pharma Limited
Find a price of Thiotepa bulk with DMF offered by Natco Pharma Limited
Find a price of Tipiracil Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Trifluridine bulk with DMF offered by Natco Pharma Limited
Find a price of Zolmitriptan bulk with DMF offered by Natco Pharma Limited
Find a price of Acalabrutinib bulk with DMF offered by Natco Pharma Limited
Find a price of Alectinib Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Cabozantinib bulk with DMF offered by Natco Pharma Limited
Find a price of Capmatinib Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Cidofovir bulk with DMF offered by Natco Pharma Limited
Find a price of Eribulin bulk with DMF offered by Natco Pharma Limited
Find a price of Granisetron Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Ibrutinib bulk with DMF offered by Natco Pharma Limited
Find a price of Idelalisib bulk with DMF offered by Natco Pharma Limited
Find a price of Letrozole bulk with DMF offered by Natco Pharma Limited
Find a price of Lurbinectedin bulk with DMF offered by Natco Pharma Limited
Find a price of Ondansetron Hydrochloride bulk with DMF offered by Natco Pharma Limited
Find a price of Risdiplam bulk with DMF offered by Natco Pharma Limited
Find a price of Rizatriptan Benzoate bulk with DMF offered by Natco Pharma Limited
Find a price of Sorafenib bulk with DMF offered by Natco Pharma Limited
Find a price of Sorafenib bulk offered by Natco Pharma Limited
Find a price of Sumatriptan bulk with DMF offered by Natco Pharma Limited
Find a price of Sumatriptan bulk offered by Natco Pharma Limited
Find a price of Ambrisentan bulk offered by Natco Pharma Limited
Find a price of Argatroban Monohydrate bulk offered by Natco Pharma Limited
Find a price of Armodafinil bulk offered by Natco Pharma Limited
Find a price of Bosentan Hydrate bulk offered by Natco Pharma Limited
Find a price of Busulfan bulk offered by Natco Pharma Limited
Find a price of Carmustine bulk offered by Natco Pharma Limited
Find a price of Dabigatran Etexilate Mesylate bulk offered by Natco Pharma Limited
Find a price of Diltiazem Hydrochloride bulk offered by Natco Pharma Limited
Find a price of Dimethyl Fumarate bulk offered by Natco Pharma Limited
Find a price of Escitalopram Oxalate bulk offered by Natco Pharma Limited
Find a price of Fluoxetine Hydrochloride bulk offered by Natco Pharma Limited
Find a price of Glatiramer Acetate bulk offered by Natco Pharma Limited
Find a price of Ledipasvir bulk offered by Natco Pharma Limited
Find a price of Lenvatinib Mesylate bulk offered by Natco Pharma Limited
Find a price of Naproxen bulk offered by Natco Pharma Limited
Find a price of Naproxen Sodium bulk offered by Natco Pharma Limited
Find a price of Omeprazole bulk offered by Natco Pharma Limited
Find a price of Osimertinib Mesylate bulk offered by Natco Pharma Limited
Find a price of Pirfenidone bulk offered by Natco Pharma Limited
Find a price of Pomalidomide bulk offered by Natco Pharma Limited
Find a price of Regorafenib bulk offered by Natco Pharma Limited
Find a price of Sugammadex Sodium bulk offered by Natco Pharma Limited
Find a price of Tamsulosin bulk offered by Natco Pharma Limited
Find a price of Tolterodine Tartrate bulk offered by Natco Pharma Limited
Find a price of Trabectedin bulk offered by Natco Pharma Limited
Find a price of Zolmitriptan bulk offered by Natco Pharma Limited
Find a price of FACILITY LOCATED IN ANDRHA PRADESH, INDIA bulk offered by Natco Pharma Limited
Find a price of Afatinib bulk offered by Natco Pharma Limited
Find a price of Baloxavir Marboxil bulk offered by Natco Pharma Limited
Find a price of Baricitinib bulk offered by Natco Pharma Limited
Find a price of Bedaquiline bulk offered by Natco Pharma Limited
Find a price of Capmatinib bulk offered by Natco Pharma Limited
Find a price of Erdafitinib bulk offered by Natco Pharma Limited
Find a price of Ixazomib Citrate bulk offered by Natco Pharma Limited
Find a price of Lapatinib Ditosylate bulk offered by Natco Pharma Limited
Find a price of Lenalidomide bulk offered by Natco Pharma Limited
Find a price of Pimavanserin Tartrate bulk offered by Natco Pharma Limited
Find a price of Ribociclib bulk offered by Natco Pharma Limited
Find a price of Rimegepant Sulfate bulk offered by Natco Pharma Limited
Find a price of Ruxolitinib Phosphate bulk offered by Natco Pharma Limited
Find a price of Tafamidis bulk offered by Natco Pharma Limited
Find a price of Tafamidis Meglumine bulk offered by Natco Pharma Limited
Find a price of Tucatinib bulk offered by Natco Pharma Limited
Find a price of Upadacitinib bulk offered by Natco Pharma Limited
Find a price of Venetoclax bulk offered by Natco Pharma Limited
Find a price of Vilanterol Trifenatate bulk offered by Natco Pharma Limited
LOOKING FOR A SUPPLIER?